精品人妻内射_欧美色色色色色色色色_韩日少妇_女人爽到高潮潮久久久_成人国产草莓视频在线观看 _成人国产无码_日韩成人无码\_色狠狠综合av熟女_久久无码视频在线观看_亚洲小说在线_人碰人人_国模冰莲自慰极品美胞_一级a一级a爱片免费_欧美日本二区_亚洲美女精品

北京索萊寶科技

專注于生物學試劑及試劑盒領域

服務熱線:18101056239

產品中心

PRODUCTS CENTER

當前位置:首頁產品中心抗體Polyclonal AntibodyK106610PAnti-LTF Polyclonal Antibody

Anti-LTF Polyclonal Antibody
產品簡介:

Anti-LTF Polyclonal Antibody
應用 IHC
稀釋比例IHC 1:50-200.
交叉反應Human

產品型號:K106610P

更新時間:2022-08-15

廠商性質:生產廠家

訪 問 量 :953

服務熱線

010-50973130

立即咨詢
產品介紹

Anti-LTF Polyclonal Antibody

英文名稱Anti-LTF Polyclonal Antibody
宿主Rabbit
別名GIG12;HEL110;HLF2;LF
應用IHC
稀釋比例IHC 1:50-200.
交叉反應Human
蛋白分子量73kDa
Gene ID4057
保存Store at -20°C. Avoid freeze / thaw cycles.
儲存液Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
純化方法Affinity purification
亞型IgG
免疫原A synthetic peptide of human LTF
性狀液體
Public Immunogen RangeA synthetic peptide of human LTF
Subcellular LocationsNucleus Cytoplasm Secreted
Swiss ProtP02788
克隆類型Polyclonal Antibody
背景資料This gene is a member of the transferrin family of genes and its protein product is found in the secondary granules of neutrophils. The protein is a major iron-binding protein in milk and body secretions with an antimicrobial activity, making it an important component of the non-specific immune system. The protein demonstrates a broad spectrum of properties, including regulation of iron homeostasis, host defense against a broad range of microbial infections, anti-inflammatory activity, regulation of cellular growth and differentiation and protection against cancer development and metastasis. Antimicrobial, antiviral, antifungal and antiparasitic activity has been found for this protein and its peptides. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

在線留言

ONLINE MESSAGE

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7
  • 服務熱線 010-50973130
  • 電子郵箱

    3193328036@qq.com

掃碼加微信

Copyright © 2025 北京索萊寶科技有限公司版權所有    備案號:

技術支持:化工儀器網    sitemap.xml

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |